-
公开(公告)号:US20210301250A1
公开(公告)日:2021-09-30
申请号:US17267028
申请日:2019-08-08
发明人: Yuki ISHIKAWA , Tadaomi KAWASHIMA , Masaki ADACHI , Naoki SHIMOJO
IPC分类号: C12N1/20 , A61K35/744 , A23L33/135 , A23L2/52 , G01N33/68
摘要: The purpose of the present invention is to provide a composition containing, as an active ingredient, a substance having rich history of use in foods or an ingestion experience in human and having an effect of inhibiting FcεRI expression on a pDC. This purpose can be achieved by a composition for activating plasmacytoid dendritic cell comprising: at least one active ingredient selected from the group consisting of a bacterial cell, a bacterial component, and a culture of Pediococcus lactic acid bacteria, and a product obtained by treating any one of them, and having an effect of inhibiting FcεRI expression on a plasmacytoid dendritic cell.